HomeCompareHNHPF vs PFE

HNHPF vs PFE: Dividend Comparison 2026

HNHPF yields 3.23% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HNHPF wins by $43.4K in total portfolio value
10 years
HNHPF
HNHPF
● Live price
3.23%
Share price
$11.98
Annual div
$0.39
5Y div CAGR
38.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$93.0K
Annual income
$27,927.47
Full HNHPF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — HNHPF vs PFE

📍 HNHPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHNHPFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HNHPF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HNHPF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HNHPF
Annual income on $10K today (after 15% tax)
$274.40/yr
After 10yr DRIP, annual income (after tax)
$23,738.35/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, HNHPF beats the other by $1,418.45/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HNHPF + PFE for your $10,000?

HNHPF: 50%PFE: 50%
100% PFE50/50100% HNHPF
Portfolio after 10yr
$71.3K
Annual income
$27,093.09/yr
Blended yield
38.01%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

HNHPF
No analyst data
Altman Z
3.0
Piotroski
5/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HNHPF buys
0
PFE buys
0
No recent congressional trades found for HNHPF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHNHPFPFE
Forward yield3.23%6.13%
Annual dividend / share$0.39$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR38.6%13.2%
Portfolio after 10y$93.0K$49.6K
Annual income after 10y$27,927.47$26,258.71
Total dividends collected$65.8K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: HNHPF vs PFE ($10,000, DRIP)

YearHNHPF PortfolioHNHPF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$11,147$447.43$9,153$693.39+$2.0KHNHPF
2$12,574$646.07$8,593$849.25+$4.0KHNHPF
3$14,398$943.96$8,336$1,066.78+$6.1KHNHPF
4$16,806$1,400.12$8,437$1,384.80+$8.4KHNHPF
5$20,099$2,116.93$9,013$1,875.40+$11.1KHNHPF
6$24,786$3,279.46$10,306$2,680.72+$14.5KHNHPF
7$31,759$5,238.45$12,820$4,101.38+$18.9KHNHPF
8$42,677$8,694.61$17,673$6,826.70+$25.0KHNHPF
9$60,798$15,134.00$27,543$12,591.86+$33.3KHNHPF
10$92,982$27,927.47$49,560$26,258.71+$43.4KHNHPF

HNHPF vs PFE: Complete Analysis 2026

HNHPFStock

Hon Hai Precision Industry Co., Ltd. provides technology solutions in Japan, Ireland, the United States, Singapore, China, Taiwan, and internationally. The company manufactures, sells, and services connectors, cases, thermal modules, wired/wireless communication products, optical products, power supply modules, and assemblies for use in the information technology, communications, automotive equipment, precision molding, automobile, and consumer electronics industries. It also manufactures and sells computer terminal monitors and related components, as well as data storage and processing equipment; offers solutions for autonomous driving systems, new energy power, and IoV systems; and provides services of planning, advisory, and business operation and management, logistics, export processing, construction, leasing, and information/software services. In addition, the company manufactures and sells application modules and network cables assemblies; develops educational technology; holds patent applications; manufactures and trades in portable cameras; and retails office machinery and equipment, and electronic appliances. Further, it is involved in the reinvestment in the businesses relating to robots, automatic equipment, molds, parts, and accessories and corresponding services; and software development, repair and after-sale, and rental services of robots. Additionally, the company manufactures and sells computer and data processing equipment, WIFI cards and modules, CFTVs, DVRs, Bluetooth modules, set-top boxes, and optical network terminals. It is also involved in the provision of data storage services; manufacturing of wire or wireless communication; installation of computer and satellite TV channels; and provision of mobile phone services, as well as telecom-related business. The company was founded in 1974 and is headquartered in New Taipei City, Taiwan.

Full HNHPF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this HNHPF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HNHPF vs SCHDHNHPF vs JEPIHNHPF vs OHNHPF vs KOHNHPF vs MAINHNHPF vs JNJHNHPF vs MRKHNHPF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.